{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:53:38Z","timestamp":1790402018208,"version":"4.1.0"},"reference-count":120,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T00:00:00Z","timestamp":1592179200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T00:00:00Z","timestamp":1592179200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1038\/s41423-020-0482-z","type":"journal-article","created":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T12:03:27Z","timestamp":1592222607000},"page":"799-806","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Variations in killer-cell immunoglobulin-like receptor and human leukocyte antigen genes and immunity to malaria"],"prefix":"10.1038","volume":"17","author":[{"given":"Stephen","family":"Tukwasibwe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2806-0243","authenticated-orcid":false,"given":"Annettee","family":"Nakimuli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Traherne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olympe","family":"Chazara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyothi","family":"Jayaraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Trowsdale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8388-9073","authenticated-orcid":false,"given":"Ashley","family":"Moffett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasanna","family":"Jagannathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J.","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Cose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5193-6376","authenticated-orcid":false,"given":"Francesco","family":"Colucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,15]]},"reference":[{"key":"482_CR1","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/S0140-6736(18)30324-6","volume":"391","author":"EA Ashley","year":"2018","unstructured":"Ashley, E. A., Pyae Phyo, A. & Woodrow, C. J. Malaria. Lancet 391, 1608\u20131621 (2018).","journal-title":"Lancet"},{"key":"482_CR2","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.3389\/fmicb.2016.01617","volume":"7","author":"PS Gomes","year":"2016","unstructured":"Gomes, P. S., Bhardwaj, J., Rivera-Correa, J., Freire-De-Lima, C. G. & Morrot, A. Immune escape strategies of malaria parasites. Front. Microbiol. 7, 1617 (2016).","journal-title":"Front. Microbiol"},{"key":"482_CR3","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.3389\/fimmu.2018.03006","volume":"9","author":"DC Gowda","year":"2018","unstructured":"Gowda, D. C. & Wu, X. Parasite recognition and signaling mechanisms in innate immune responses to malaria. Front. Immunol. 9, 3006 (2018).","journal-title":"Front. Immunol"},{"key":"482_CR4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1128\/CMR.00025-08","volume":"22","author":"DL Doolan","year":"2009","unstructured":"Doolan, D. L., Doba\u00f1o, C. & Baird, J. K. Acquired immunity to malaria. Clin. Microbiol. Rev. 22, 13 (2009).","journal-title":"Clin. Microbiol. Rev."},{"key":"482_CR5","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2875-13-121","volume":"13","author":"AJ Nhabomba","year":"2014","unstructured":"Nhabomba, A. J. et al. Impact of age of first exposure to Plasmodium falciparum on antibody responses to malaria in children: a randomized, controlled trial in Mozambique. Malar. J. 13, 121 (2014).","journal-title":"Malar. J."},{"key":"482_CR6","doi-asserted-by":"crossref","DOI":"10.1186\/s12936-018-2195-7","volume":"17","author":"R Varo","year":"2018","unstructured":"Varo, R. et al. Adjunctive therapy for severe malaria: a review and critical appraisal. Malar. J. 17, 47 (2018).","journal-title":"Malar. J."},{"key":"482_CR7","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMp1613528","volume":"375","author":"K Maitland","year":"2016","unstructured":"Maitland, K. Severe malaria in African children - the need for continuing investment. N. Engl. J. Med. 375, 2416\u20132417 (2016).","journal-title":"N. Engl. J. Med."},{"key":"482_CR8","doi-asserted-by":"crossref","first-page":"e0203229","DOI":"10.1371\/journal.pone.0203229","volume":"13","author":"A Mpimbaza","year":"2018","unstructured":"Mpimbaza, A. et al. Associations between erythrocyte polymorphisms and s uncomplicated and severe malaria in Ugandan children: a case control study. PLoS ONE 13, e0203229\u2013e0203229 (2018).","journal-title":"PLoS ONE"},{"key":"482_CR9","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/bjh.14886","volume":"179","author":"MM Goheen","year":"2017","unstructured":"Goheen, M. M., Campino, S. & Cerami, C. The role of the red blood cell in host defence against falciparum malaria: an expanding repertoire of evolutionary alterations. Br. J. Haematol. 179, 543\u201356. (2017).","journal-title":"Br. J. Haematol."},{"key":"482_CR10","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1182\/blood.V96.7.2358","volume":"96","author":"A Agarwal","year":"2000","unstructured":"Agarwal, A. et al. Hemoglobin C associated with from severe malaria in the Dogon of Mali, a West African population with a low prevalence of hemoglobin S. Blood 96, 2358\u20132363 (2000).","journal-title":"Blood"},{"key":"482_CR11","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1086\/422847","volume":"190","author":"FP Mockenhaupt","year":"2004","unstructured":"Mockenhaupt, F. P. et al. Hemoglobin C and resistance to severe malaria in Ghanaian children. J. Infect. Dis. 190, 1006\u20131009 (2004).","journal-title":"J. Infect. Dis."},{"key":"482_CR12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1086\/432519","volume":"77","author":"DP Kwiatkowski","year":"2005","unstructured":"Kwiatkowski, D. P. How malaria has affected the human genome and what human genetics can teach us about malaria. Am. J. Hum. Genet. 77, 171\u2013192 (2005).","journal-title":"Am. J. Hum. Genet."},{"key":"482_CR13","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ajhg.2016.06.023","volume":"99","author":"PJ Norman","year":"2016","unstructured":"Norman, P. J. et al. Defining KIR and HLA class I genotypes at highest resolution via high-throughput sequencing. Am. J. Hum. Genet. 99, 375\u2013391 (2016).","journal-title":"Am. J. Hum. Genet."},{"key":"482_CR14","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-017-1207-1","volume":"18","author":"V Matzaraki","year":"2017","unstructured":"Matzaraki, V., Kumar, V., Wijmenga, C. & Zhernakova, A. The MHC locus and genetic susceptibility to autoimmune and infectious diseases. Genome Biol. 18, 76 (2017).","journal-title":"Genome Biol."},{"key":"482_CR15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s40744-018-0100-z","volume":"5","author":"G Bodis","year":"2018","unstructured":"Bodis, G., Toth, V. & Schwarting, A. Role of human leukocyte antigens (HLA) in autoimmune diseases. Rheumatol. Ther. 5, 5\u201320 (2018).","journal-title":"Rheumatol. Ther."},{"key":"482_CR16","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1182\/blood-2017-08-752170","volume":"131","author":"S Cooley","year":"2018","unstructured":"Cooley, S., Parham, P. & Miller, J. S. Strategies to activate NK cells to prevent relapse and induce remission following hematopoietic stem cell transplantation. Blood 131, 1053 (2018).","journal-title":"Blood"},{"key":"482_CR17","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3389\/fnins.2016.00463","volume":"10","author":"AR Torres","year":"2016","unstructured":"Torres, A. R., Sweeten, T. L., Johnson, R. C., Odell, D., Westover, J. B., Bray-Ward, P. et al. Common genetic variants found in HLA and KIR immune genes in autism spectrum disorder. Front. Neurosci. 10, 463 (2016).","journal-title":"Front. Neurosci"},{"key":"482_CR18","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00251-017-1003-9","volume":"69","author":"F Colucci","year":"2017","unstructured":"Colucci, F. The role of KIR and HLA interactions in pregnancy complications. Immunogenetics 69, 557\u201365. (2017).","journal-title":"Immunogenetics"},{"key":"482_CR19","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-016-0358-0","volume":"8","author":"W Jiang","year":"2016","unstructured":"Jiang, W. et al. qKAT: a high-throughput qPCR method for KIR gene copy number and haplotype determination. Genome Med. 8, 99 (2016).","journal-title":"Genome Med."},{"key":"482_CR20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00251-017-1017-3","volume":"70","author":"DC Meyer","year":"2018","unstructured":"Meyer, D. C., Aguiar, V. R., Bitarello, B. D. C., Brandt, D. Y. & Nunes, K. A genomic perspective on HLA evolution. Immunogenetics 70, 5\u201327 (2018).","journal-title":"Immunogenetics"},{"key":"482_CR21","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-016-1093-y","volume":"17","author":"L Quintana-Murci","year":"2016","unstructured":"Quintana-Murci, L. Understanding rare and common diseases in the context of human evolution. Genome Biol. 17, 225 (2016).","journal-title":"Genome Biol."},{"key":"482_CR22","volume":"8","author":"S Dhiman","year":"2019","unstructured":"Dhiman, S. Are malaria elimination efforts on right track? An analysis of gains achieved and challenges ahead. Infect. Dis. Poverty 8, 14 (2019).","journal-title":"Infect. Dis. Poverty"},{"key":"482_CR23","volume":"16","author":"JN Burrows","year":"2017","unstructured":"Burrows, J. N. et al. New developments in anti-malarial target candidate and product profiles. Malar. J. 16, 26 (2017).","journal-title":"Malar. J."},{"key":"482_CR24","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s40265-018-0911-9","volume":"78","author":"EA Ashley","year":"2018","unstructured":"Ashley, E. A. & Phyo, A. P. Drugs in development for malaria. Drugs 78, 861\u201379. (2018).","journal-title":"Drugs"},{"key":"482_CR25","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1051\/parasite\/2014059","volume":"21","author":"S Sinha","year":"2014","unstructured":"Sinha, S., Medhi, B. & Sehgal, R. Challenges of drug-resistant malaria. Parasite 21, 61 (2014).","journal-title":"Parasite"},{"key":"482_CR26","volume":"11","author":"L-M Birkholtz","year":"2012","unstructured":"Birkholtz, L.-M., Bornman, R., Focke, W., Mutero, C. & de Jager, C. Sustainable malaria control: transdisciplinary approaches for translational applications. Malar. J. 11, 431 (2012).","journal-title":"Malar. J."},{"key":"482_CR27","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3389\/fimmu.2019.00135","volume":"10","author":"A Ssemaganda","year":"2019","unstructured":"Ssemaganda, A. et al. Induction of Plasmodium-specific immune responses using liposome-based vaccines. Front. Immunol. 10, 135 (2019). -.","journal-title":"Front. Immunol."},{"key":"482_CR28","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-017-0035-3","volume":"2","author":"CH Coelho","year":"2017","unstructured":"Coelho, C. H., Doritchamou, J. Y. A., Zaidi, I. & Duffy, P. E. Advances in malaria vaccine development: report from the 2017 malaria vaccine symposium. npj Vaccines. 2, 34 (2017).","journal-title":"npj Vaccines."},{"key":"482_CR29","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1093\/cid\/ciu954","volume":"60","author":"A Ouattara","year":"2014","unstructured":"Ouattara, A. & Laurens, M. B. Vaccines against malaria. Clin. Infect. Dis. 60, 930\u2013936 (2014).","journal-title":"Clin. Infect. Dis."},{"key":"482_CR30","volume":"20","author":"M van den Berg","year":"2019","unstructured":"van den Berg, M., Ogutu, B., Sewankambo, N. K., Biller-Andorno, N. & Tanner, M. RTS,S malaria vaccine pilot studies: addressing the human realities in large-scale clinical trials. Trials 20, 316 (2019).","journal-title":"Trials"},{"key":"482_CR31","doi-asserted-by":"crossref","first-page":"e1001994","DOI":"10.1371\/journal.pmed.1001994","volume":"13","author":"R Gosling","year":"2016","unstructured":"Gosling, R. & von Seidlein, L. The future of the RTS,S\/AS01 malaria vaccine: an alternative development plan. PLoS Med. 13, e1001994 (2016).","journal-title":"PLoS Med."},{"key":"482_CR32","doi-asserted-by":"crossref","first-page":"eaau1458","DOI":"10.1126\/scitranslmed.aau1458","volume":"11","author":"JG Beeson","year":"2019","unstructured":"Beeson, J. G. et al. Challenges and strategies for developing efficacious and long-lasting malaria vaccines. Sci. Transl. Med. 11, eaau1458 (2019).","journal-title":"Sci. Transl. Med."},{"key":"482_CR33","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3389\/fimmu.2016.00251","volume":"7","author":"K Pallmer","year":"2016","unstructured":"Pallmer, K. & Oxenius, A. Recognition and regulation of T cells by NK cells. Front. Immunol. 7, 251 (2016).","journal-title":"Front. Immunol"},{"key":"482_CR34","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3389\/fimmu.2019.00177","volume":"10","author":"EE Wroblewski","year":"2019","unstructured":"Wroblewski, E. E., Parham, P. & Guethlein, L. A. Two to tango: co-evolution of hominid natural killer cell receptors and MHC. Front. Immunol. 10, 177 (2019).","journal-title":"Front. Immunol"},{"key":"482_CR35","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.3389\/fimmu.2019.01179","volume":"10","author":"D Pende","year":"2019","unstructured":"Pende, D. et al. Killer Ig-like receptors (KIRs): their role in NK cell modulation and developments leading to their clinical exploitation. Front. Immunol. 10, 1179 (2019).","journal-title":"Front. Immunol."},{"key":"482_CR36","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1365-2567.2009.03208.x","volume":"129","author":"D Middleton","year":"2010","unstructured":"Middleton, D. & Gonzelez, F. The extensive polymorphism of KIR genes. Immunology 129, 8\u201319 (2010).","journal-title":"Immunology"},{"key":"482_CR37","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.smim.2008.10.002","volume":"20","author":"P Parham","year":"2008","unstructured":"Parham, P. The genetic and evolutionary balances in human NK cell receptor diversity. Semin. Immunol. 20, 311\u2013316 (2008).","journal-title":"Semin. Immunol."},{"key":"482_CR38","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/imm.12684","volume":"150","author":"V B\u00e9ziat","year":"2017","unstructured":"B\u00e9ziat, V., Hilton, H. G., Norman, P. J. & Traherne, J. A. Deciphering the killer-cell immunoglobulin-like receptor system at super-resolution for natural killer and T-cell biology. Immunology. 150, 248\u2013264 (2017).","journal-title":"Immunology"},{"key":"482_CR39","doi-asserted-by":"crossref","first-page":"6208","DOI":"10.4049\/jimmunol.168.12.6208","volume":"168","author":"M Faure","year":"2002","unstructured":"Faure, M. & Long, E. O. KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential. J. Immunol. 168, 6208 (2002).","journal-title":"J. Immunol."},{"key":"482_CR40","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.rbmo.2016.08.019","volume":"33","author":"A Moffett","year":"2016","unstructured":"Moffett, A., Chazara, O., Colucci, F. & Johnson, M. H. Variation of maternal KIR and fetal HLA-C genes in reproductive failure: too early for clinical intervention. Reprod. BioMedicine Online 33, 763\u2013769 (2016).","journal-title":"Reprod. BioMedicine Online"},{"key":"482_CR41","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1365-2567.2010.03398.x","volume":"132","author":"KS Campbell","year":"2011","unstructured":"Campbell, K. S. & Purdy, A. K. Structure\/function of human killer cell immunoglobulin-like receptors: lessons from polymorphisms, evolution, crystal structures and mutations. Immunology 132, 315\u2013325 (2011).","journal-title":"Immunology"},{"key":"482_CR42","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3389\/fimmu.2012.00336","volume":"3","author":"AK Moesta","year":"2012","unstructured":"Moesta, A. K. & Parham, P. Diverse functionality among human NK cell receptors for the C1 epitope of HLA-C: KIR2DS2, KIR2DL2, and KIR2DL3. Front. Immunol. 3, 336 (2012). -.","journal-title":"Front. Immunol."},{"key":"482_CR43","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1365-2567.2009.03045.x","volume":"126","author":"K Cheent","year":"2009","unstructured":"Cheent, K. & Khakoo, S. I. Natural killer cells: integrating diversity with function. Immunology 126, 449\u2013457 (2009).","journal-title":"Immunology"},{"key":"482_CR44","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cell.2010.08.031","volume":"142","author":"MT Orr","year":"2010","unstructured":"Orr, M. T. & Lanier, L. L. Natural killer cell education and tolerance. Cell 142, 847\u2013856 (2010).","journal-title":"Cell"},{"key":"482_CR45","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3389\/fimmu.2012.00336","volume":"3","author":"A Moesta","year":"2012","unstructured":"Moesta, A. & Parham, P. Diverse functionality among human NK cell receptors for the C1 epitope of HLA-C: KIR2DS2, KIR2DL2, and KIR2DL3. Front Immunol. 3, 336 (2012).","journal-title":"Front Immunol"},{"key":"482_CR46","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/imm.12802","volume":"152","author":"F Colucci","year":"2017","unstructured":"Colucci, F. & Traherne, J. Killer-cell immunoglobulin-like receptors on the cusp of modern immunogenetics. Immunology 152, 556\u2013561 (2017).","journal-title":"Immunology"},{"key":"482_CR47","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1101\/gr.137976.112","volume":"22","author":"W Jiang","year":"2012","unstructured":"Jiang, W. et al. Copy number variation leads to considerable diversity for B but not A haplotypes of the human KIR genes encoding NK cell receptors. Genome Res. 22, 1845\u20131854 (2012).","journal-title":"Genome Res."},{"key":"482_CR48","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00251-008-0331-1","volume":"60","author":"RM Single","year":"2008","unstructured":"Single, R. M., Martin, M. P., Meyer, D., Gao, X. & Carrington, M. Methods for assessing gene content diversity of KIR with examples from a global set of populations. Immunogenetics 60, 711\u2013725 (2008).","journal-title":"Immunogenetics"},{"key":"482_CR49","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00251-016-0935-9","volume":"68","author":"BS Penman","year":"2016","unstructured":"Penman, B. S., Moffett, A., Chazara, O., Gupta, S. & Parham, P. Reproduction, infection and killer-cell immunoglobulin-like receptor haplotype evolution. Immunogenetics 68, 755\u201364. (2016).","journal-title":"Immunogenetics"},{"key":"482_CR50","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nri3370","volume":"13","author":"P Parham","year":"2013","unstructured":"Parham, P. & Moffett, A. Variable NK cell receptors and their MHC class I ligands in immunity, reproduction and human evolution. Nat. Rev. Immunol. 13, 133\u2013144 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"482_CR51","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1126\/science.1097670","volume":"305","author":"SI Khakoo","year":"2004","unstructured":"Khakoo, S. I. et al. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 305, 872\u2013874 (2004).","journal-title":"Science"},{"key":"482_CR52","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/ng2035","volume":"39","author":"MP Martin","year":"2007","unstructured":"Martin, M. P. et al. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat. Genet. 39, 733\u2013740 (2007).","journal-title":"Nat. Genet."},{"key":"482_CR53","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/imr.12326","volume":"267","author":"LA Guethlein","year":"2015","unstructured":"Guethlein, L. A., Norman, P. J., Hilton, H. G. & Parham, P. Co-evolution of MHC class I and variable NK cell receptors in placental mammals. Immunological Rev. 267, 259\u2013282 (2015).","journal-title":"Immunological Rev."},{"key":"482_CR54","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.it.2017.12.001","volume":"39","author":"JE Boudreau","year":"2018","unstructured":"Boudreau, J. E. & Hsu, K. C. Natural killer cell education and the response to infection and cancer therapy: stay tuned. Trends Immunol. 39, 222\u2013239 (2018).","journal-title":"Trends Immunol."},{"key":"482_CR55","doi-asserted-by":"crossref","first-page":"7466","DOI":"10.4049\/jimmunol.175.11.7466","volume":"175","author":"DS Korbel","year":"2005","unstructured":"Korbel, D. S., Newman, K. C., Almeida, C. R., Davis, D. M. & Riley, E. M. Heterogeneous human NK cell responses to Plasmodium falciparum-infected erythrocytes. J. Immunol. 175, 7466 (2005).","journal-title":"J. Immunol."},{"key":"482_CR56","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3349\/ymj.2007.48.1.11","volume":"48","author":"SY Choo","year":"2007","unstructured":"Choo, S. Y. The HLA system: genetics, immunology, clinical testing, and clinical implications. Yonsei Med. J. 48, 11\u201323 (2007).","journal-title":"Yonsei Med. J."},{"key":"482_CR57","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/sji.12329","volume":"82","author":"YM Mosaad","year":"2015","unstructured":"Mosaad, Y. M. Clinical role of human leukocyte antigen in health and disease. Scand. J. Immunol. 82, 283\u2013306 (2015).","journal-title":"Scand. J. Immunol."},{"key":"482_CR58","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.it.2016.08.010","volume":"37","author":"KL Rock","year":"2016","unstructured":"Rock, K. L., Reits, E. & Neefjes, J. Present yourself! by MHC class I and MHC class II molecules. Trends Immunol. 37, 724\u2013737 (2016).","journal-title":"Trends Immunol."},{"key":"482_CR59","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/gene.2016.5","volume":"17","author":"JA Hollenbach","year":"2016","unstructured":"Hollenbach, J. A., Pando, M. J., Caillier, S. J., Gourraud, P. A. & Oksenberg, J. R. The killer immunoglobulin-like receptor KIR3DL1 in combination with HLA-Bw4 is protective against multiple sclerosis in African Americans. Genes Immun. 17, 199\u2013202 (2016).","journal-title":"Genes Immun."},{"key":"482_CR60","doi-asserted-by":"crossref","first-page":"e0163570","DOI":"10.1371\/journal.pone.0163570","volume":"11","author":"F Carlini","year":"2016","unstructured":"Carlini, F. et al. Association of HLA-A and non-classical HLA class I alleles. PLoS ONE 11, e0163570 (2016).","journal-title":"PLoS ONE"},{"key":"482_CR61","doi-asserted-by":"crossref","unstructured":"Durmanova, V., Homolova, M., Drobny, J., Shawkatov\u00e1, I. & Buc, M. Role of HLA-G and other immune mechanisms in pregnancy. Central Eur. J. Biol. 8 (2013).","DOI":"10.2478\/s11535-013-0130-4"},{"key":"482_CR62","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.3389\/fimmu.2018.02410","volume":"9","author":"A R\u00f6lle","year":"2018","unstructured":"R\u00f6lle, A., J\u00e4ger, D. & Momburg, F. HLA-E peptide repertoire and dimorphism\u2014centerpieces in the adaptive NK cell puzzle? Front. Immunol. 9, 2410 (2018).","journal-title":"Front. Immunol"},{"key":"482_CR63","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00251-011-0513-0","volume":"63","author":"J Greenbaum","year":"2011","unstructured":"Greenbaum, J. et al. Functional classification of class II human leukocyte antigen (HLA) molecules reveal seven different supertypes and a surprising degree of repertoire sharing across supertypes. Immunogenetics 63, 325\u2013335 (2011).","journal-title":"Immunogenetics"},{"key":"482_CR64","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3389\/fimmu.2019.00229","volume":"10","author":"R Kumar","year":"2019","unstructured":"Kumar, R., Ng, S. & Engwerda, C. The role of IL-10 in malaria: a double edged sword. Front. Immunol. 10, 229 (2019).","journal-title":"Front. Immunol"},{"key":"482_CR65","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1128\/IAI.02796-14","volume":"83","author":"P Liehl","year":"2015","unstructured":"Liehl, P. et al. Innate immunity induced by Plasmodium liver infection inhibits malaria reinfections. Infect. Immun. 83, 1172 (2015).","journal-title":"Infect. Immun."},{"key":"482_CR66","doi-asserted-by":"crossref","first-page":"e1004079","DOI":"10.1371\/journal.ppat.1004079","volume":"10","author":"S Portugal","year":"2014","unstructured":"Portugal, S. et al. Exposure-dependent control of malaria-induced inflammation in children. PLoS Pathog. 10, e1004079\u2013e1004079 (2014).","journal-title":"PLoS Pathog."},{"key":"482_CR67","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1128\/IAI.02398-14","volume":"83","author":"DI Stanisic","year":"2015","unstructured":"Stanisic, D. I. et al. Acquisition of antibodies against Plasmodium falciparum merozoites and malaria immunity in young children and the influence of age, force of infection, and magnitude of response. Infect. Immun. 83, 646 (2015).","journal-title":"Infect. Immun."},{"key":"482_CR68","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/s41590-018-0228-6","volume":"19","author":"IA Cockburn","year":"2018","unstructured":"Cockburn, I. A. & Seder, R. A. Malaria prevention: from immunological concepts to effective vaccines and protective antibodies. Nat. Immunol. 19, 1199\u20131211 (2018).","journal-title":"Nat. Immunol."},{"key":"482_CR69","doi-asserted-by":"crossref","first-page":"e0185303","DOI":"10.1371\/journal.pone.0185303","volume":"12","author":"KA Kusi","year":"2017","unstructured":"Kusi, K. A. et al. Variations in the quality of malaria-specific antibodies with transmission intensity in a seasonal malaria transmission area of Northern Ghana. PLoS ONE 12, e0185303 (2017).","journal-title":"PLoS ONE"},{"key":"482_CR70","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3389\/fimmu.2019.00559","volume":"10","author":"A Ly","year":"2019","unstructured":"Ly, A. & Hansen, D. S. Development of B cell memory in malaria. Front. Immunol. 10, 559 (2019).","journal-title":"Front. Immunol"},{"key":"482_CR71","doi-asserted-by":"crossref","DOI":"10.1186\/s12936-017-2148-6","volume":"16","author":"L Farrington","year":"2017","unstructured":"Farrington, L. et al. Both inflammatory and regulatory cytokine responses to malaria are blunted with increasing age in highly exposed children. Malar. J. 16, 499 (2017).","journal-title":"Malar. J."},{"key":"482_CR72","doi-asserted-by":"crossref","first-page":"e1005812","DOI":"10.1371\/journal.pcbi.1005812","volume":"13","author":"JJ Valletta","year":"2017","unstructured":"Valletta, J. J. & Recker, M. Identification of immune signatures predictive of clinical from malaria. PLoS computational Biol. 13, e1005812 (2017).","journal-title":"PLoS computational Biol."},{"key":"482_CR73","doi-asserted-by":"crossref","first-page":"e36806","DOI":"10.7554\/eLife.36806","volume":"7","author":"G Arora","year":"2018","unstructured":"Arora, G. et al. NK cells inhibit Plasmodium falciparum growth in red blood cells via antibody-dependent cellular cytotoxicity. eLife 7, e36806 (2018).","journal-title":"eLife"},{"key":"482_CR74","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/MOH.0000000000000135","volume":"22","author":"AS Paul","year":"2015","unstructured":"Paul, A. S., Egan, E. S. & Duraisingh, M. T. Host-parasite interactions that guide red blood cell invasion by malaria parasites. Curr. Opin. Hematol. 22, 220\u2013226 (2015).","journal-title":"Curr. Opin. Hematol."},{"key":"482_CR75","first-page":"167","volume":"5","author":"A Gharehbaghian","year":"2006","unstructured":"Gharehbaghian, A., Donaldson, C., Newman, J., Bannister, G. & Bradley, B. A. The correlation between the percent of CD3- CD56+ cells and NK precursor function. Iran. J. Allergy Asthma Immunol. 5, 167\u2013175 (2006).","journal-title":"Iran. J. Allergy Asthma Immunol."},{"key":"482_CR76","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-21443-5","volume":"8","author":"ME Rebuli","year":"2018","unstructured":"Rebuli, M. E., Pawlak, E. A., Walsh, D., Martin, E. M. & Jaspers, I. Distinguishing human peripheral blood NK cells from CD56dimCD16dimCD69+CD103+ resident nasal mucosal lavage fluid cells. Sci. Rep. 8, 3394 (2018).","journal-title":"Sci. Rep."},{"key":"482_CR77","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3389\/fimmu.2017.00699","volume":"8","author":"M Amand","year":"2017","unstructured":"Amand, M. et al. Human CD56(dim)CD16(dim) cells as an individualized natural killer cell subset. Front. Immunol. 8, 699 (2017).","journal-title":"Front. Immunol."},{"key":"482_CR78","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.4049\/jimmunol.1502570","volume":"196","author":"T Michel","year":"2016","unstructured":"Michel, T. et al. Human CD56 NK cells: an update. J. Immunol. 196, 2923 (2016).","journal-title":"J. Immunol."},{"key":"482_CR79","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1182\/blood-2009-08-238469","volume":"115","author":"C Fauriat","year":"2010","unstructured":"Fauriat, C., Long, E. O., Ljunggren, H.-G. & Bryceson, Y. T. Regulation of human NK-cell cytokine and chemokine production by target cell recognition. Blood 115, 2167\u20132176 (2010).","journal-title":"Blood"},{"key":"482_CR80","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1002\/1521-4141(2001010)31:10<3121::AID-IMMU3121>3.0.CO;2-4","volume":"31","author":"R Jacobs","year":"2001","unstructured":"Jacobs, R. et al. CD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells. Eur. J. Immunol. 31, 3121\u20133126 (2001).","journal-title":"Eur. J. Immunol."},{"key":"482_CR81","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.3389\/fimmu.2017.01976","volume":"8","author":"Q Hammer","year":"2018","unstructured":"Hammer, Q., R\u00fcckert, T., Dunst, J. & Romagnani, C. Adaptive natural killer cells integrate interleukin-18 during target-cell encounter. Front. Immunol. 8, 1976 (2018).","journal-title":"Front. Immunol."},{"key":"482_CR82","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.immuni.2015.02.008","volume":"42","author":"H Schlums","year":"2015","unstructured":"Schlums, H. et al. Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function. Immunity 42, 443\u2013456. (2015).","journal-title":"Immunity"},{"key":"482_CR83","first-page":"212","volume":"8","author":"A-S Wolf","year":"2017","unstructured":"Wolf, A.-S., Sherratt, S. & Riley, E. M. NK cells: uncertain allies against malaria. Front. Immunol. 8, 212 (2017).","journal-title":"Front. Immunol."},{"key":"482_CR84","volume":"8","author":"A Obaid","year":"2018","unstructured":"Obaid, A. et al. Model of the adaptive immune response system against HCV infection reveals potential immunomodulatory agents for combination therapy. Sci. Rep. 8, 8874 (2018).","journal-title":"Sci. Rep."},{"key":"482_CR85","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1182\/bloodadvances.2017015404","volume":"2","author":"CS Forconi","year":"2018","unstructured":"Forconi, C. S. et al. Poorly cytotoxic terminally differentiated CD56negCD16pos NK cells accumulate in Kenyan children with Burkitt lymphomas. Blood Adv. 2, 1101\u20131114 (2018).","journal-title":"Blood Adv."},{"key":"482_CR86","first-page":"1206737","volume":"2018","author":"P Liu","year":"2018","unstructured":"Liu, P., Chen, L. & Zhang, H. Natural killer cells in liver disease and hepatocellular carcinoma and the NK cell-based immunotherapy. J. Immunol. Res. 2018, 1206737 (2018).","journal-title":"J. Immunol. Res."},{"key":"482_CR87","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1084\/jem.20181681","volume":"216","author":"GT Hart","year":"2019","unstructured":"Hart, G. T. et al. Adaptive NK cells in people exposed to Plasmodium falciparum correlate with from malaria. J. Exp. Med. 216, 1280\u20131290 (2019).","journal-title":"J. Exp. Med."},{"key":"482_CR88","doi-asserted-by":"crossref","DOI":"10.1186\/s12936-019-2953-1","volume":"18","author":"KS Burrack","year":"2019","unstructured":"Burrack, K. S., Hart, G. T. & Hamilton, S. E. Contributions of natural killer cells to the immune response against Plasmodium. Malar. J. 18, 321 (2019).","journal-title":"Malar. J."},{"key":"482_CR89","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/eji.201646762","volume":"48","author":"MR Goodier","year":"2018","unstructured":"Goodier, M. R., Jonji\u0107, S., Riley, E. M. & Jurani\u0107 Lisni\u0107, V. CMV and natural killer cells: shaping the response to vaccination. Eur. J. Immunol. 48, 50\u201365 (2018).","journal-title":"Eur. J. Immunol."},{"key":"482_CR90","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jcv.2007.10.027","volume":"41","author":"GWG Wilkinson","year":"2008","unstructured":"Wilkinson, G. W. G. et al. Modulation of natural killer cells by human cytomegalovirus. J. Clin. Virol. 41, 206\u2013212 (2008).","journal-title":"J. Clin. Virol."},{"key":"482_CR91","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3389\/fmed.2017.00117","volume":"4","author":"L Sharma","year":"2017","unstructured":"Sharma, L. & Shukla, G. Placental malaria: a new insight into the pathophysiology. Front. Med. 4, 117 (2017).","journal-title":"Front. Med."},{"key":"482_CR92","volume":"19","author":"T Oth","year":"2018","unstructured":"Oth, T. et al. Pathogen recognition by NK cells amplifies the pro-inflammatory cytokine production of monocyte-derived DC via IFN-\u03b3. BMC Immunol. 19, 8 (2018).","journal-title":"BMC Immunol."},{"key":"482_CR93","doi-asserted-by":"crossref","first-page":"e1005708","DOI":"10.1371\/journal.ppat.1005708","volume":"12","author":"SE Clark","year":"2016","unstructured":"Clark, S. E. et al. Bacterial manipulation of NK cell regulatory activity increases susceptibility to listeria monocytogenes Infection. PLoS Pathog. 12, e1005708 (2016).","journal-title":"PLoS Pathog."},{"key":"482_CR94","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1128\/IAI.01420-07","volume":"76","author":"C Othoro","year":"2008","unstructured":"Othoro, C. et al. Elevated gamma interferon-producing NK cells, CD45RO memory-like T cells, and CD4 T cells are associated with protection against malaria infection in pregnancy. Infect. Immun. 76, 1678\u20131685 (2008).","journal-title":"Infect. Immun."},{"key":"482_CR95","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1172\/JCI68107","volume":"124","author":"A Moffett","year":"2014","unstructured":"Moffett, A. & Colucci, F. Uterine NK cells: active regulators at the maternal-fetal interface. The. J. Clin. Investig. 124, 1872\u20131879 (2014).","journal-title":"J. Clin. Investig."},{"key":"482_CR96","doi-asserted-by":"crossref","first-page":"e38617","DOI":"10.1371\/journal.pone.0038617","volume":"7","author":"YO Omosun","year":"2012","unstructured":"Omosun, Y. O. et al. Differential association of gene content polymorphisms of killer cell immunoglobulin-like receptors with placental malaria in HIV- and HIV+ mothers. PLoS ONE 7, e38617\u2013e38617 (2012).","journal-title":"PLoS ONE"},{"key":"482_CR97","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1399-0039.2011.01818.x","volume":"79","author":"LM Yindom","year":"2012","unstructured":"Yindom, L. M. et al. Killer-cell immunoglobulin-like receptors and malaria caused by Plasmodium falciparum in The Gambia. Tissue Antigens 79, 104\u2013113 (2012).","journal-title":"Tissue Antigens"},{"key":"482_CR98","doi-asserted-by":"crossref","first-page":"7466","DOI":"10.4049\/jimmunol.175.11.7466","volume":"175","author":"DS Korbel","year":"2005","unstructured":"Korbel, D. S., Newman, K. C., Almeida, C. R., Davis, D. M. & Riley, E. M. Heterogeneous human NK cell responses to Plasmodium falciparum-infected erythrocytes. J. Immunol. 175, 7466\u20137473 (2005).","journal-title":"J. Immunol."},{"key":"482_CR99","first-page":"212","volume":"8","author":"A-S Wolf","year":"2017","unstructured":"Wolf, A.-S., Sherratt, S. & Riley, E. M. NK cells: uncertain allies against malaria. Front Immunol. 8, 212 (2017).","journal-title":"Front Immunol"},{"key":"482_CR100","doi-asserted-by":"crossref","first-page":"e1002565","DOI":"10.1371\/journal.ppat.1002565","volume":"8","author":"K Hirayasu","year":"2012","unstructured":"Hirayasu, K. et al. Significant association of KIR2DL3-HLA-C1 combination with cerebral malaria and implications for co-evolution of KIR and HLA. PLoS Pathog. 8, e1002565\u2013e1002565 (2012).","journal-title":"PLoS Pathog."},{"key":"482_CR101","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.humimm.2014.06.002","volume":"75","author":"SA Olaniyan","year":"2014","unstructured":"Olaniyan, S. A. et al. Killer-cell immunoglobulin-like receptors and falciparum malaria in southwest Nigeria. Hum. Immunol. 75, 816\u2013821 (2014).","journal-title":"Hum. Immunol."},{"key":"482_CR102","doi-asserted-by":"crossref","first-page":"e1003938","DOI":"10.1371\/journal.pgen.1003938","volume":"9","author":"PJ Norman","year":"2013","unstructured":"Norman, P. J. et al. Co-evolution of human leukocyte antigen (HLA) class I ligands with killer-cell immunoglobulin-like receptors (KIR) in a genetically diverse population of sub-Saharan Africans. PLoS Genet. 9, e1003938\u2013e1003938 (2013).","journal-title":"PLoS Genet."},{"key":"482_CR103","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.actatropica.2017.10.026","volume":"178","author":"S Prakash","year":"2018","unstructured":"Prakash, S., Ranjan, P., Ghoshal, U. & Agrawal, S. KIR-like activating natural killer cell receptors and their association with complicated malaria in north India. Acta Trop. 178, 55\u201360 (2018).","journal-title":"Acta Trop."},{"key":"482_CR104","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00251-009-0401-z","volume":"61","author":"M Taniguchi","year":"2009","unstructured":"Taniguchi, M. & Kawabata, M. KIR3DL1\/S1 genotypes and KIR2DS4 allelic variants in the AB KIR genotypes are associated with Plasmodium-positive individuals in malaria infection. Immunogenetics 61, 717\u2013730 (2009).","journal-title":"Immunogenetics"},{"key":"482_CR105","doi-asserted-by":"crossref","first-page":"5396","DOI":"10.4049\/jimmunol.171.10.5396","volume":"171","author":"K Artavanis-Tsakonas","year":"2003","unstructured":"Artavanis-Tsakonas, K. et al. Activation of a subset of human NK cells upon contact with Plasmodium falciparum-infected erythrocytes. J. Immunol. 171, 5396 (2003).","journal-title":"J. Immunol."},{"key":"482_CR106","doi-asserted-by":"crossref","first-page":"6426","DOI":"10.4049\/jimmunol.0804224","volume":"182","author":"DS Korbel","year":"2009","unstructured":"Korbel, D. S. et al. Killer Ig-like receptor (KIR) genotype predicts the capacity of human KIR-positive CD56dim NK cells to respond to pathogen-associated signals. J. Immunol. 182, 6426\u20136434 (2009).","journal-title":"J. Immunol."},{"key":"482_CR107","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1128\/CMR.00048-08","volume":"22","author":"JM Blackwell","year":"2009","unstructured":"Blackwell, J. M., Jamieson, S. E. & Burgner, D. HLA and infectious diseases. Clin. Microbiol. Rev. 22, 370\u2013385 (2009).","journal-title":"Clin. Microbiol. Rev."},{"key":"482_CR108","doi-asserted-by":"crossref","first-page":"6529681","DOI":"10.1155\/2018\/6529681","volume":"2018","author":"EB Belachew","year":"2018","unstructured":"Belachew, E. B. Immune response and evasion mechanisms of Plasmodium falciparum parasites. J. Immunol. Res 2018, 6529681 (2018).","journal-title":"J. Immunol. Res"},{"key":"482_CR109","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.humimm.2008.08.294","volume":"69","author":"K Ghosh","year":"2008","unstructured":"Ghosh, K. Evolution and selection of human leukocyte antigen alleles by Plasmodium falciparum infection. Hum. Immunol. 69, 856\u2013860 (2008).","journal-title":"Hum. Immunol."},{"key":"482_CR110","first-page":"76","volume":"39","author":"U Shankarkumar","year":"2002","unstructured":"Shankarkumar, U. et al. HLA associations in P. falciparum malaria patients from Mumbai, western India. Indian J. Malariol. 39, 76\u201382 (2002).","journal-title":"Indian J. Malariol."},{"key":"482_CR111","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7883\/yoken.JJID.2005.25","volume":"58","author":"H Hananantachai","year":"2005","unstructured":"Hananantachai, H. et al. Polymorphisms of the HLA-B and HLA-DRB1 genes in Thai malaria patients. Jpn J. Infect. Dis. 58, 25\u201328 (2005).","journal-title":"Jpn J. Infect. Dis."},{"key":"482_CR112","first-page":"25","volume":"43","author":"M Ndiaye","year":"1998","unstructured":"Ndiaye, M. et al. Susceptibility to neuro-malaria and HLA-DR alleles in Senegal. Dakar Med. 43, 25\u201328 (1998).","journal-title":"Dakar Med."},{"key":"482_CR113","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1098\/rstb.1994.0155","volume":"346","author":"VSH Adrian","year":"1994","unstructured":"Adrian, V. S. H. et al. Human leukocyte antigens and natural selection by malaria. Philos. Trans. 346, 379\u2013385 (1994).","journal-title":"Philos. Trans."},{"key":"482_CR114","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1073\/pnas.1413453112","volume":"112","author":"A Nakimuli","year":"2015","unstructured":"Nakimuli, A. et al. A KIR B centromeric region present in Africans but not Europeans protects pregnant women from pre-eclampsia. Proc. Natl Acad. Sci. USA 112, 845\u2013850 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"482_CR115","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/360434a0","volume":"360","author":"AV Hill","year":"1992","unstructured":"Hill, A. V. et al. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 360, 434\u2013439 (1992).","journal-title":"Nature"},{"key":"482_CR116","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1399-0039.1996.tb02693.x","volume":"48","author":"K Hirayama","year":"1996","unstructured":"Hirayama, K. et al. Molecular analysis of HLA-B in the Malaysian aborigines. Tissue Antigens 48, 692\u2013697 (1996).","journal-title":"Tissue Antigens"},{"key":"482_CR117","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1399-0039.1998.tb03072.x","volume":"52","author":"L Contu","year":"1998","unstructured":"Contu, L. et al. HLA-B35 frequency variations correlate with malaria infection in Sardinia. Tissue Antigens 52, 452\u2013461 (1998).","journal-title":"Tissue Antigens"},{"key":"482_CR118","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1034\/j.1399-0039.2001.057006502.x","volume":"57","author":"NK Mehra","year":"2001","unstructured":"Mehra, N. K., Jaini, R., Rajalingam, R., Balamurugan, A. & Kaur, G. Molecular diversity of HLA-A*02 in Asian Indians: predominance of A*0211. Tissue antigens 57, 502\u2013507 (2001).","journal-title":"Tissue antigens"},{"key":"482_CR119","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/352595a0","volume":"352","author":"AV Hill","year":"1991","unstructured":"Hill, A. V. et al. Common west African HLA antigens are associated with from severe malaria. Nature 352, 595\u2013600 (1991).","journal-title":"Nature"},{"key":"482_CR120","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1034\/j.1399-0039.2002.590603.x","volume":"59","author":"M Busson","year":"2002","unstructured":"Busson, M. et al. HLA-DRB1 and DQB1 allele distribution in the Muong population exposed to malaria in Vietnam. Tissue Antigens 59, 470\u2013474 (2002).","journal-title":"Tissue Antigens"}],"container-title":["Cellular &amp; Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41423-020-0482-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-020-0482-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-020-0482-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T05:51:23Z","timestamp":1744177883000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41423-020-0482-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,15]]},"references-count":120,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["482"],"URL":"https:\/\/doi.org\/10.1038\/s41423-020-0482-z","relation":{},"ISSN":["1672-7681","2042-0226"],"issn-type":[{"value":"1672-7681","type":"print"},{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,15]]},"assertion":[{"value":"5 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"O.C. had started in a role as an employee of AstraZeneca, UK, at the time of manuscript preparation. Other authors have declared that no competing conflicts of interest exist.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}